US Patent Issued to ZHEJIANG HISUN PHARMACEUTICAL, SHANGHAI ARYL PHARMTECH on April 21 for "Salt of tetrahydroisoquinoline derivative, preparation method therefor, and medical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,551, issued on April 21, was assigned to ZHEJIANG HISUN PHARMACEUTICAL Co. LTD. (Taizhou, China) and SHANGHAI ARYL PHARMTECH Co. LTD. (Shanghai).

"Salt of tetrahydroisoquinoline derivative, preparation method therefor, and medical use thereof" was invented by Yanghui Guo (Shanghai), Lichen Meng (Shanghai), Xiangui Huang (Shanghai), Weiwei Liao (Shanghai), Yongxiang Gong (Taizhou, China), Daiwang Xu (Shanghai), Taishan Hu (Shanghai) and Lei Chen (Taizhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutically acceptable salt of (S)-2-(6-fluorobenzo[d]oxazol-2-yl)-6-methoxy-5-((5-methoxypyridin-2-yl))...